Allen Mooney & Barnes Investment Advisors’s CVS Health CVS Stock Holding History

Allen Mooney & Barnes Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-131,097	Closed	-$7.74M	–	156
2024 Q2	$7.74M	Buy	131,097 +2,934	+2%	+$184K	1.38%	27
2024 Q1	$8.94M	Sell	128,163 -686	-0.5%	-$52.4K	1.72%	25
2023 Q4	$10.2M	Sell	128,849 -2,687	-2%	-$191K	1.93%	19
2023 Q3	$9.18M	Buy	131,536 +6,946	+6%	+$492K	1.96%	23
2023 Q2	$8.61M	Sell	124,590 -34	-0%	-$2.42K	1.91%	20
2023 Q1	$9.26M	Buy	124,624 +5,609	+5%	+$470K	2.22%	16
2022 Q4	$11.1M	Buy	119,015 +3,143	+3%	+$303K	2.67%	8
2022 Q3	$11.1M	Buy	115,872 +1,666	+1%	+$165K	2.95%	4
2022 Q2	$10.6M	Buy	114,206 +6,715	+6%	+$655K	2.71%	8
2022 Q1	$10.9M	Buy	+107,491	New	+$11.3M	2.41%	9

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Allen Mooney & Barnes Investment Advisors's CVS Position: Q3 2024 in Review

Allen Mooney & Barnes Investment Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 131,097 shares — an estimated $7.74M sold.

Allen Mooney & Barnes Investment Advisors first reported a position in CVS in Q1 2022 and held it in 10 quarters. The position peaked at $11.1M in Q4 2022. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Allen Mooney & Barnes Investment Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Allen Mooney & Barnes Investment Advisors sold 131,097 CVS Health shares in Q3 2024, an estimated $7.74M.
Allen Mooney & Barnes Investment Advisors first reported a position in CVS Health in Q1 2022 and held it in 10 quarters.
Allen Mooney & Barnes Investment Advisors's CVS Health position peaked at $11.1M in Q4 2022.
1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.